EFPIA
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
EFPIA targets MEPs in social media campaign
March 17, 2014Medical Communications, Sales and Marketing EFPIA, EU, bergstrom, pharma summit, social media
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign aimed at MEPs. With ten …
Novartis extends trial transparency
February 27, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
EFPIA appoints comms head from Lilly
February 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, English, liam, lilly
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has hired its new comms director from Eli Lilly. Liam English …
Germany focus: strength with control
February 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE
Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …
EU GMP revision comments focus on cross-contamination
December 3, 2013Manufacturing and Production Contamination, EFPIA, EU, GMP
Earlier this year the EU Commission published draft versions of four chapters in its Good Manufacturing Practice (GMP) guide, and …
EMA bows to pressure on its own transparency
October 8, 2013Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Guido Rasi, transparency
The European Medicines Agency (EMA)’s management board has agreed to publish agendas and minutes from the meetings of all the …
Fake drugs warning from pharma
September 13, 2013Manufacturing and Production, Sales and Marketing EFPIA, WHO, counterfeit, viagra
Pharma has warned that not enough is being done to protect consumers from counterfeit medicines – particularly those bought online …
EFPIA slams EMA data proposals
September 10, 2013Research and Development, Sales and Marketing AZ, EFPIA, EMA, GSK, Pfizer, Roche
The intense debate over how pharma should make trial data available has taken another turn as a major European industry …
ABPI publishes trial disclosure ‘toolkit’
August 15, 2013Medical Communications, Sales and Marketing ABPI, EFPIA, Goldacre, transparency
The ABPI has today launched a new clinical trial disclosure toolkit to help pharma companies meet data transparency requirements. The …
Pharma groups want limited data release
July 24, 2013Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency
The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …
Secret EFPIA memo on data transparency leaked
July 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, EMA, PhRMA, transparency
A memo from the European pharma lobby group EFPIA has revealed that the industry is trying to ‘mobilise’ patient groups …
Pharma chemicals added to EU pollutant watch list
July 9, 2013Manufacturing and Production EFPIA, EU, WFD, pollutants
For the first time, three pharmaceutical compounds – two hormones and an anti-inflammatory drug – will be included in a …
Tighter rules on pharma gifts challenged by manufacturers
July 4, 2013Manufacturing and Production, Medical Communications, Sales and Marketing EFPIA, EPPA, promotional products, transparency
The pharma industry could face a series of lawsuits by manufacturers of promotional gifts as new rules look to ban …
Pharma to disclose doctor payments
July 4, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, pharma, transparency
Pharma companies in Europe will have to reveal how much they pay to doctors under a voluntary agreement set out …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
